The Heart in Sickle Cell Anemia

Wesley Covitz(National Heart Lung and Blood Institute), Norman S. Talner(National Institutes of Health), Sanford Leff(National Heart Lung and Blood Institute), William E. Hellenbrand(Yale New Haven Hospital), Mark A. Espeland(Wake Forest University), Dianne Gallagher(New England Research Institutes)

CHEST Journal

November 1, 1995

10.1378/chest.108.5.1214

Cited by 144

Related Papers

Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes

|Diabetes Care|2007|1.5k

Effect of Structured Physical Activity on Prevention of Major Mobility Disability in Older Adults

|JAMA|2014|1.4k

Metformin as a Tool to Target Aging

|Cell Metabolism|2016|1.1k

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

|JAMA|1995|605

Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. A case-control study.

|Circulation|1990|557